| 000 | 01228 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514034137.0 | ||
| 264 | 0 | _c20020913 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a1462-2416 | ||
| 024 | 7 |
_a10.1517/14622416.3.3.341 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurlong, Clement E | |
| 245 | 0 | 0 |
_aPharmacogenomic considerations of the paraoxonase polymorphisms. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cMay 2002 |
||
| 300 |
_a341-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAryldialkylphosphatase |
| 650 | 0 | 4 |
_aEsterases _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xmetabolism |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aVascular Diseases _xenzymology |
| 700 | 1 | _aCole, Toby B | |
| 700 | 1 | _aJarvik, Gail P | |
| 700 | 1 | _aCosta, Lucio G | |
| 773 | 0 |
_tPharmacogenomics _gvol. 3 _gno. 3 _gp. 341-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14622416.3.3.341 _zAvailable from publisher's website |
| 999 |
_c11948346 _d11948346 |
||